Showing results (81-90 of 473) with videos related to

Sort By:
Pageof 48
Hereditary Cancer in Clinical Practice|March 29, 2019
Single-center study of Lynch syndrome screening in colorectal polypsFangChao Zhu, Da Pan, Hui Zhang, et al.
Hereditary Cancer in Clinical Practice|July 18, 2019
Allelic variants of breast cancer susceptibility genes PALB2 and RECQL in the Latvian populationPhilip Hilz, Reicela Heinrihsone, Lukas Alexander Pätzold, et al.
Hereditary Cancer in Clinical Practice|July 25, 2019
Colorectal carcinoma in the course of inflammatory bowel diseasesAndrzej Hnatyszyn, Szymon Hryhorowicz, Marta Kaczmarek-Ryś, et al.
Hereditary Cancer in Clinical Practice|January 28, 2017
Hereditary cancer syndromes in Latino populations: genetic characterization and surveillance guidelinesMarcia Cruz-Correa, Julyann Pérez-Mayoral, Julie Dutil, et al.
Hereditary Cancer in Clinical Practice|September 14, 2019
A family pedigree of malignancies associated with BRCA1 pathogenic variants: a reflection of the state of art in ChinaWenhui Li, Lei Li, Ming Wu
Hereditary Cancer in Clinical Practice|January 28, 2023
The complementary roles of genome-wide approaches in identifying genes linked to an inherited risk of colorectal cancerOlfat Ahmad, Asta Försti
Hereditary Cancer in Clinical Practice|January 28, 2023
Germline heterozygous exons 8-11 pathogenic BARD1 gene deletion reported for the first time in a family with suspicion of a hereditary colorectal cancer syndrome: more than an incidental finding?Sergio Carrera, Ana Belén Rodríguez-Martínez, Intza Garin, et al.
Hereditary Cancer in Clinical Practice|March 7, 2023
Are population level familial risks and germline genetics meeting each other?Kari Hemminki, Xinjun Li, Asta Försti, et al.
Hereditary Cancer in Clinical Practice|August 9, 2020
Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish populationKatarzyna Białkowska, Wojciech Marciniak, Magdalena Muszyńska, et al.
Hereditary Cancer in Clinical Practice|August 8, 2020
Informing patients about their mutation tests: CDKN2A c.256G>A in melanoma as an exampleKari Hemminki, Aayushi Srivastava, Sivaramakrishna Rachakonda, et al.
Pageof 48